-
This retrospective chart review covered all patients with vulvodynia treated with gabapentin at a single facility between January of 2002 and September of 2004.
-
Legro and colleagues, reporting for the Cooperative Multicenter Reproductive Medicine Network, presented the results of a multicenter, randomized trial indicating that clomiphene is superior to metformin in achieving live births in women with the polycystic ovary (PCO) syndrome.
-
It has not been clear as to whether a cervical conization truly predisposes a patient to preterm birth (PTB). The authors of this enlightening paper set out to see if the interval between the procedure and subsequent conception had any effect on the incidence of PTB.
-
-
What is your approach when it comes to treatment of partners of patients with sexually transmitted diseases (STDs)? A new research analysis indicates that patient-delivered partner therapy (PDPT) and home sampling for partners can be effective management strategies to reduce STD occurrence in partners of patients with an existing infection.
-
Working to eliminate syphilis in your patient population? Use the practical materials available in the Syphilis Elimination Effort (SEE) toolkit developed by the Centers for Disease Control and Prevention (CDC).
-
What is your clinic doing to boost syphilis testing? An innovative social marketing campaign, "Healthy Penis," has been associated with an increase in syphilis tests in gay and bisexual men in San Francisco.
-
Women who are interested in nonhormonal contraception will see wider access to the Today contraceptive sponge now that a new company is in charge of its marketing and distribution.
-
The next patient in your examination room is an adolescent female who says she wants the "acne pill." What are your options?
-
Students who seek contraceptive services at college and university health centers are facing sticker shock when it comes to picking up their supplies. As a result of changes to the federal Deficit Reduction Act (DRA) that were implemented in January 2007, institutions of higher education no longer qualify for special reduced pricing for contraceptive supplies.